Table 2.
Outcomes of the study cohort.
| Outcomes | Cohort (n = 1394) |
|---|---|
| Hospital length of stay (d) | 13 (6–26) |
| MAKE 30, n (%) | |
| Death | 66 (4.7) |
| Receipt of new RRT | 124 (8.9) |
| PRD | 233 (16.7) |
| Total | 336 (24.1) |
| 90-day adverse outcomes, n (%) | |
| Death | 99 (7.1) |
| Chronic dialysis | 14 (1.0) |
| Total | 113 (8.1) |
MAKE30, Major Adverse Kidney Events within 30 days.
Continuous variables are presented as median (interquartile range) and categorical variables are presented as n (%).
RRT renal replacement therapy, PRD persistent renal dysfunction.